Применение антидепрессантов различных фармакологических групп в комплесном лечении хронических нейропатических болей
Диссертация
Тригеминальная невралгия (ТН) и диабетическая полинейропатия (ДПН) являются типичными примерами периферической хронической НБ, соответственно, пароксизмального и перманентного характера. ТН является одной из самых распространённых прозопалгий и относится к числу наиболее устойчивых болевых синдромов в клинической неврологии. ДПН является второй по частоте встречаемости причиной НБ. Хроническая… Читать ещё >
Список литературы
- Аметов A.C., Строков И. А. Диабетическая иолинейропатия настоящее и будущее // Российские медицинские вести. — 2001. — Т. 4, № 1. С. 35−40.
- Андреева Н.И., Аснина В. В., Либерман С. С. Отечественные антидепрессанты. Азафен // Хим.-фармацсвтич. жури.- 2000. Т. 5. — С. 16−20.
- Анисимова Е.И., Данилов А. Б. Нейропатический болевой синдром: клинико-нейрофизиологический анализ // Журн. неврол. и психиатр, им. С. С. Корсакова. — 2003.-Т. 103, № 10.-С. 15−20.
- Антонова К.В.,. Недосугова Л. В Роль и место тиоктовой кислоты в комплексной терапии сахарного диабета // Журнал «Трудный пациент» / Архив 2008. — № 10. -С. 17−22.
- Балаболкин М.И. Диабетология. М.: Медицина, 2000. — 672 с.
- Балаболкин М.И., Клебанова Е. М., Креминская В. М. Лечение сахарного диабета и его осложнений. М.: Медицина, 2005. — 512 с.
- Баринов А.Н., Яхно H.H. Лечение пейропатической боли // Русский медицинский журнал. 2003. — T. II, № 25. — С. 1419−1422.
- Болевые синдромы в неврологической практике / Под ред. A.M. Вейна. М.: МЕДпресс-информ, 2001.-368 с.
- Вегетативные расстройства: Клиника, диагностика, лечение / Под ред. A.M. Вейна. -М.: ООО «Медицинское информационное агентство», 2003. 752 с.
- Вейн A.M. Заболевания вегетативной нервной системы. М., 1991. — 624 с.
- Вейн A.M., Авруцкий М. Я. Боль и обезболивание. — М.: Медицина, 1997. — 280 с.
- Вейн A.M., Данилов А. Б., Колосова O.A. и др. Мигрень: динамика психофизиологического паттерна // Журн. невропатол. и психиатр, им. С. С. Корсакова. -2000.-Т. 100,№ 12. С. 13−20.
- Гамбург А.Л., Лившиц Л. Я., Кром В. А., Ямпольский Л. Б. Психофармакотерапия психических нарушений у больных с хронической болью // Неврологический вестник. 1994. — Т. XXVI, Вып. 3−4. — С. 28−31.
- Гокин А.П., Словачек М. Ретикулярные структуры и ретикулоспинальные пути, участвующие в инициации и торможении спино-бульбо-спинальной активности //
- Нейрофизиология. 1976. — Т. 8, № 4. — С. 373−383.
- Григорян Ю.А. Нейрогенные лицевые боли (патогенез, диагностика и микрохирургия): Дис.. д-ра мед. наук. М., 1996. — 370 с.
- Данилов А.Б. Комплексный регионарный болевой синдром // В кн.: Вегетативные расстройства / Под ред. Вейпа A.M. М., 1998. — С. 604−615.
- Данилов А.Б., Давыдов О. С. Нейропатическая боль. М.: Боргес, 2007. — 192 с.
- Данилов А.Б., Данилов Ал.Б., Вейн A.M. Ноцицептивный флексорный рефлекс: метод изучения церебральных механизмов боли (обзор) // Журн. невропат, и психиатр, им. С. С. Корсакова. 1996. -№ 1. — С. 107−112.
- Данилов А.Б., Данилов Ал.Б., Вейн A.M. Экстероцептивная супрессия мышечной активности: новый метод изучения центральных ноцицептивных механизмов // Журн. невропатол. и психиатр, им. С. С. Корсакова. — 1995. № 3. — С.90−93.
- Дедов И.И., Балаболкин М. И., Мамаева Г. Г. и др. Сахарный диабет: ангиопатии и окислительный стресс. Пособие для врачей. М., 2003. 85 с.
- Дзяк Л. А., Зозуля O.A. Диабетическая полинейропатия (этиопатогенез, клиника, диагностика, лечение) // Международный неврологический журнал. 2008. — № 4 (20). -С. 61−71.
- Дробижев М.Ю., Изнак А. Ф. Нейрональная пластичность новая мишень в терапии депрессий. — М., 2003. — 24 с.
- Дюкова Г. М. Новые перспективы лечения хронической боли и депрессии // Consilium Medicum. 2008. — Т. 9, № 8. — С. 85−87.
- Карлов В.А. Неврология лица. М.: Медицина, 1991. — 288 с.
- Коржавина В.Б. Головная боль напряжения: клинико-психо-нейрофизиологический анализ: Дисс.. канд.мед.наук. М., 2008. — 136 с.
- Котов С. В., Калинин А. П., Рудакова И. Г. Диабетическая нейропатия. М.: Медицина, 2000. — 228 с.
- Крыжановский Г. Н. Детерминантные структуры в патологии нервной системы. М.: Медицина, 1980.-360 с.
- Крыжановский Г. Н. Общая патофизиология нервной системы. — М.: Медицина, 1997. -352 с.
- Крыжановский Г. Н. Центральные механизмы патологической боли // Журн. невропатол. и психиатр. 1999. — Т. 12. — С. 4−7.
- Кукушкин M.JI. Общая патология боли. М.: Медицина, 2004. — 144 с.
- Левин О.С. Полиневропатия. М.: МИА, 2006. 496 с.
- Машковский М.Д. Лекарственные средства. // М.: Медицина, 1996. С. 121.
- Мелзак Р. Загадка боли. M.: Медицина, 1981. — 231 с.
- Мингазова JI.P. Клинико-физиологический анализ и лечение миофасциального болевого синдрома лица: Дисс.. канд. мед. наук. М., 2005. — 171 с.
- Мосолов С.Н. Клиническое применение современных антидепрессантов. СПб: МИА, 1995.-568 с.
- Павленко С.С. Эпидемиология боли // Неврол. журн. 1999. — Т. 4, № 1. — С. 41−46.
- Райский В.А. Психотропные средства в клинике внутренних болезней. М.: Медицина, 1982.- 192 с.
- Решетняк В.К., Кукушкин M.JI. Боль: физиологические и патофизиологические аспекты. // В кн.: Актуальные вопросы патофизиологии (избранные лекции) / Под ред. Б. Б. Мороз. М., Медицина, 2001. — С.354−389.
- Степанченко A.B., Шаров М. Н. Применение габапентина при лечении обострений невралгии тройничного нерва // Боль. — 2005. — Т. 3, № 8. — С. 58−61.
- Строков И. А., Баринов А. II. Клиника, патогенез и лечение болевого синдрома при диабетической полиневропатии // Неврол. журн 2001. — № 6. — С. 47−55.
- Строков И.А., Строков К. И., Ахмеджанова Л. Л., Албекова Ж. С. Тиоктацид в лечении диабетической полиневропатии // Журнал «Трудный пациент» / Архив — 2008. № 12. -С. 19−23.
- Табеева Г. Р., Вейн A.M. Фармакотерапия депрессии // Consilium Medicum. 2004. — T. 6, № 1.-С. 72−76.
- Табеева Г. Р., Левин Я. И., Короткова С. Б. Лечение фибромиалгии // Журн. невропат, и психиатр, им. С. С. Корсакова. 1998. — № 4. — С. 40−43.
- Турбина Л. Г. Лицевые боли // Учебное пособие. М., 2002. — 31 с.
- Ханин Ю.Л. Краткое руководство к применению шкалы реактивной и личностной тревожности Ч.Д. Спилбергера. Л., 1976. — 18 с.
- Шинаев H.H., Дачевская И. И., Акжигитов Р. Г. Опыт лечения пограничных психических расстройств в «Клинике неврозов». // Российский психиатрический журнал. -2000. № 1. — С. 54−58.
- Шмидт Р. Ноцицепция и боль // Физиология человека в 4-х томах / Под ред. Р. Шмидт, Г. Тевс: Пер. с английского. М.: Мир, 1996. — Т.1. — С. 222−234.
- Шнайдер H.A., Петрова М. М., Киричкова Г. А. Диабетическая невропатия // Международный неврологический журнал. — 2008. № 3 (19). — С. 115−119.
- Adelman L.C., Adelman J.U., Von Seggern R., Mannix L.K. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinic setting // Headache. 2000. — Vol. 40. — P. 572−580.
- Aktekin B., Yaltkaya K., Ozkaynak S., Oguz Y. Recovery Cycle of the Blink Reflex and Exteroceptive Suppression of Temporalis Muscle Activity in Migraine and Tension-type Headache //Headache. -2001. -Vol. 41.-P. 142−149.
- Amos A.F., McCarty D.J., Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010 // Diabetes Med. — 1997. —Bd. 14 (Suppl. 5). S. 1−85.
- Andersen R.K., Lund J.P., Puil E. Excitation and inhibition of neurons in the trigeminal nucleus caudalis following periaqueductal gray stimulation // Can. J. Physiol. Pharmacol. — 1978.-Vol. 56.-P. 157−161.
- Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis // Diabetes Care. 2001. —Vol. 24. -P. 1069- 1078.
- Antonaci F., Sandrini G., Danilov A., Sand T. Neurophysiological studies in chronic paroxysmal hemicrania and hemicrania continua // Headache. — 1994.— Vol. 34, N.8. -P. 479−483. '
- Aramideh M., Ongerboer de Visser B.W. Brainstem reflexes: electrodiagnostic techniques, physiology, normative data, and clinical applications // Muscle Nerve. 2002. — Vol. 26.- P. 14−30.
- Arezzo J.C., Rosenstock J., LaMoreaux L., Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial // BMC Neurol. 2008. — Vol. 8. — P.33.
- Attal N., Cruccu G., Haanpaa M. et al. EFNS guidelines on pharmacological treatment of neuropathic pain//European Journal of Neurology.— 2006.-Vol. 13. —P. 1153−1169.
- Aurora S. Temporalis exteroceptive and tension-type headache // Cephalalgia. 1996. — Vol. 16.-P. 216−219.
- Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial // JAMA.- 1998.-Vol. 280.-P. 1831−1836.
- Backonja M., Glanzman R.L. Gabapentic dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials // Clin. Ther. 2003. — Vol. 25. — P. 81−104.
- Backonja M., Serra J. Pharmacologic management part 1: better-studied neuropathic paindeseases // Pain Med. 2004. — Vol. 5 (Suppl.l). — P. 28−47.
- Bansal V., Kalita J., Misra U. K. Diabetic neuropathy // Postgrad. Med. J. 2006. — Vol. 82. -P. 95−100.
- Barker F.G., Jannetta P.J., Bissonette D.J. et al. The long-term outcome of microvascular decompression for trigeminal neuralgia // N. Engl. J. Med. 1996. — Vol. 334. — P. 10 771 083.
- Barkin R.L. Attributes, and advantages of venlafaxine overlooked // Formulary. — 1998. — Vol. 33.-P. 74−75.
- Barkin R., Fawcett J. The management challenges of chronic pain: the role of antidepressants // Am. J. Ther. 2000. — Vol. 7. — P. 37−47.
- Basbaum A.I. Anatomical substrates of pain and pain modulation and their relationship to analgesic drugs // Analgesics: neurochemical, behavioral and clinical perspective / Eds. M. Kuhar, C. Pasternac. -New York, Raven Press, 1984. P.97−123.
- Beck A.T., Ward C.M., Mendelson M. et al. An inventory for measuring depression // Arch. Gen. Psychiat. 1961.-Vol. 5.- P. 561 -571.
- Belgrade M.J. Following the clues to neuropathic pain. Distribution and other leads reveal the cause and the treatment approach // Postgrad. Med. 1999. — Vol. 106, N. 6. — P. 127 140.
- Bendtsen L., Jensen R., Brennum J. et al. Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state // Cephalalgia. 1996. — Vol. 16. — P. 251−256.
- Bendtsen L., Jensen R., Brennum J. et al. Exteroceptive suppression period in jaw-closing muscles. Variability and relation to experimental pain and sustained muscle contraction // Cephalalgia.- 1993.-Vol. 13. P. 184−191.
- Bennet G.J., Nishikawa N., Lu G.W. et al. The morphology of dorsal column postsynaptic spinomedullary neurons in the cat // J. Comp. Neurol. 1984. -Vol. 224. — P. 568.
- Bennet M. (ed). Neuropathic pain. Oxford University Press, 2006. — 176 p.
- Berger A., Dukes E.M., Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders // Pain. 2004. — Vol. 5. — P. 143−149.
- Besson J.M. The neurobiology of pain. // Lancet. 1999. — Vol. 353. — P. 1610−1615.
- Bierhaus A., Chevion S., Chevion M. et al. Advanced glycation end product-inducedactivation of NF-kB is suppressed by a-lipoic acid in cultured endothelial cells // Diabetes. -1997.-Vol. 46.-P. 1481−1490.
- Bonica J.J. The management of pain. Philadelphia: Lea and Febiger., 1990. — 2120 p.
- Bosi E., Conti M., Vermigli C. et al. Effectiveness of frequencymodulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy // Diabetologia. 2005. — Vol. 48.-P. 817−823.
- Bouhassira D., Attal N., Alchaar H. et al. Comparison of pain syndromes associated with nervous or somatic lesion and development of a new neuropathic pain diagnostic questionnaire (DN4) // Pain. 2005. — Vol. 114. — P. 29−36.
- Boulton A.J., Malik R.A., Arezzo J.C., Sosenko J.M. Diabetic somatic neuropathies // Diabetes Care. 2004. — Vol. 27. — P. 1458−1486.
- Boulton A.J.M., Yinik A.I., Arezzo J.C.et al. Diabetic neuropathies. A statement by the American Diabetes Association // Diabetes Care. 2005. — Vol. 28. — P. 956−963.
- Bradley R.H., Barkin R.L., Jerome J. et al. Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder // Am. J. Ther. 2003. -Vol. 10, N. 5. — P. 318−323.
- Braune S. Evidence-based pharmacotherapy of neuropathic pain syndromes // MMW Fortschr. Med. 2004. — Vol. 146, N. 50. — P. 49−51.
- Breivik H, Collett B., Ventafridda V. et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment // Eur. J. Pain. 2006. — Vol. 10, N.4. — P. 287−333.
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications // Nature. —2001.-Vol. 414.-P. 813−820.
- Calcutt N.A. Potential mechanisms of neuropathic pain in diabetes // Int. Rev. Neurobiol.2002. Vol. 50. — P. 205−228.
- Callisi P.T., Jaber L.A. Peripheral diabetic neuropathy: Current concepts in treatment // Ann. Pharmacother. 1995. — Vol. 29. — P. 769−77.
- Cameron N.E., Eaton S.E., Cotter M.A., Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy // Diabetologia. — 2001. — Vol. 44. -P. 1973−1988.
- Campbell F.G., Graham J.G., Zilkha K.J. Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia // Journal of Neurology, Neurosurgery and Psychiatry. 1966. — Vol.29.-P. 265−267.
- Carr D., Goudas L. Acute pain // Lancet. 1999. — Vol. 353. — P. 2051−2058.
- Casey K.L. Supraspinal mechanisms and pain. The reticular formation // Pain and society / Eds. H.W. Kosterlitz, L.T. Terenius. Chemie, Verlag Weinheim, 1980. — P. 183−200.
- Cesaro P., Amsallet B., Pollin B. et al. Organization of the median and intralaminar nuclei of the thalamus: hypotheses on their role in the onset of certain central pain // Rev. Neurol. -1986. Vol. 142, N. 4. — P. 297−302.
- Cheshire W. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study // J. Pain. 2002. — Vol. 3. — P. 137−142.
- Chiang C.Y., Dostrovsky J.O., Sessle B.J. Periaqueductal gray matter and nucleus raphe magnus involvement in anterior pretectal nucleus-induced inhibition of jaw-opening reflex in rats // Brain Res. 1991. — Vol. 544. — P. 71−78.
- Chiang C.Y., Dostrovsky J.O., Sessle B.J. Role of anterior pretectal nucleus in somatosensory cortical descending modulation of jaw-opening reflex in rats // Brain Res. — 1989. Vol. 515. — P. 219−226.
- Chong M.S., Bajwa Z.H. Diagnosis and treatment of neuropathic pain // J. Pain Symptom Manage. 2003. — Bd. 25.- (Suppl. 5). -S. 4−11.
- Chong M.S., Hester J. Diabetic painful neuropathy: current and future treatment options // Drugs. 2007. — Vol. 67, N. 4. — P. 569−585.
- Chong M.S., Libretto S.E. The rationale and use of topiramate for treating neuropathic pain // Clin. J. Pain. 2003. — Vol. 19. — P. 59−68.
- Clark C.M., Lee D.A. Prevention and treatment of the complications of diabetes mellitus // N. Engl. J. Med. 1995. — Vol. 332. — P. 1210−1217.
- Collins S.L., Moore R.A., McQuay O. Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review // Pain Symptom Manage. 2000. — Vol. 20. — P. 449−458.
- Coquoz D., Porchet H.C., Dayer P. Central analgesic effects of desipramme, fluvoxamme, and moclobemide after single oral dosing a study in healthy volunteers // Pharmacol. Ther. -1993. Vol. 54 — P. 339−344.
- Cruccu G. Treatment of painful neuropathy // Curr. Opin. Neurol. 2007. — Vol. 20, N. 5. P.531−535.
- Cruccu G., Agostino R., Fornarelli M. et al. Recovery cycle of the masseter inhibitory reflex in man // Neuroscience Lett. 1984. — Vol. 49. — P. 63−68.
- Cruccu G., Ongerboer de Visser B.W. The jaw reflexes // Recommendations for the practice of clinical neurophysiology: Guidelines of the International Federation of Clinical
- Physiology, 2nd edn. / Eds. Deuschl G., Eisen A. // Electroencephalogr. Clin. Neurophysiol., Suppl. 52. Amsterdam: Elsevier Science, 1999. — P. 243−247.
- Cruccu G., Truini A. Trigeminal neuralgia and orofacial pains // The Neurological Basis of Pain / Ed. Pappagallo M. New York: McGraw-Hill, 2005. — P. 401−414.
- Danilov A.B. Nociceptive flexion reflex in cluster headache. VI International Headache Congress. Paris, Aug. 26−29, 1993 // Cephalalgia.- 1993, — Suppl. 13 P.201.
- Danilov A.B., Sadekov R.A., Vein A.M. Gabapentin in migraine prophylaxis. Nociceptive flexion reflex in cluster headache // Cephalalgia.- 2003. Vol. 23, N. 7. — P. 711.
- Daousi C., Benbow S.J., MacFarlane I.A. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy // Diabet. Med. 2005. — Vol. 22. — P. 393−398.
- Daousi C., MacFarlane I.A., Woodward A. et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes // Diabet Med. 2004. — Vol. 21. — P. 976−982.
- Davis J.L., Smith R.L. Painful peripheral diabetic neuropathy treated with Venlafaxine HCL extended release capsules letter. // Diabetes Care. 1999. — Vol. 22. — P. 1909−1910.
- Davies M., Brophy S., Williams R., Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes // Diabetes Care. 2006. — Vol. 29. -P. 1518−1522.
- Dawans A., Schoenen J., Timsit M., Timsit-Berthier M. Correlative study of psychopathological features and temporalis second exteroceptive silent period in chronic tension-type headache // Cephalalgia. 1991. — Vol. 11 (Suppl. 11). — P. 310−311.
- DCCT Research Group The effect of intensive diabetes therapy on the development and progression of neuropathy // Ann. Intern. Med. 1995. — Vol. 122, N. 8. — P. 561−568.
- De Broucker T.H. Cesaro P., Willier J.C., Le Bars D. Diffuse noxious inhibitory controls in man: involvement of spinoreticular tract // Brain. 1990. — Vol. 113. — P. 1223−1234.
- De Laat A., Svensson P., Macaluso G.M. Are jaw and facial reflexes modulated during clinical or experimental orofacial pain? J. Orofac. Pain. 1998. — Vol. 12. — P. 260−271.
- Dersh J., Polatii P.B., Gatchel R.J. Chronic pain and psychopathology: research findings and theoretical considerations // Psychosomat. Med. — 2002. Vol. 64. — P. 773−786.
- Desmeules J.A., Cedraschi C., Rapiti E. et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia // Arthritis Rheum. 2003. — Vol. 48, N.5. -P. 1420−1429.
- Devor M., Amir R., Rappaport Z.H. Pathophysiology of Trigeminal Neuralgia: The Ignition Hypothesis // Clin. J. Pain. 2002. — Vol. 18, N. 1. — P. 4−13.
- Dialogues in clinical neuroscience // Neuroplasticity / Ed. J-P Macher, M-A Crocq. -2004. Vol. 6, N. 2. — 250 p.
- Dogra S., Beydoun S., Mazzola J., et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebocontrolled study // Eur. J. Pain. 2005. — Vol. 9. — P. 543−554.
- Dowman R. Spinal and supraspinal correlates of nociception in man // Pain. 1991. -Vol. 45.-P. 269−281.
- Duby J.J., Campbell R.K., Setter S.M. et al. Diabetic neuropathy: an intensive review // Am. J. Health. Syst. Pharm. 2004. — Vol. 61. — P. 160−173.
- Durand J.P., Alexandre J., Guillevin L., Goldwasser F. Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy // Anticancer Drugs. -2005. Vol. 16, N.5. — P. 587−591.
- Dworkin R.H., Backonja M., Rowbotham M.C. et al. Advances in neuropathic pain: diagnosis, mechanism, and treatment recommendation // Arch. Neurol. 2003. — Vol. 60. -P. 1524−1534.
- Dyck P.J., Dyck P.J.B. Diabetic polyneuropathy // Diabetic Neuropathy / Eds. P. J. Dyck, P. K. Thomas. 2-nd Ed. Philadelphia: W. B. Saunders, 1999. — P. 255−278.
- Ebinger F. Exteroceptive suppression of masseter muscle activity in juvenile migraineurs // Cephalalgia. 2006. — Vol. 26. — P. 722−730.
- Edvinsson L, Uddman R. Neurobiology in primary headaches // Brain Res. Rev. 2005. — Vol. 48. — P.43856.
- Edwards K.R., O’Connor J.T., Button J. Levetiracetam for the treatment of trigeminal neuralgia // Epilepsia. 2004. — Vol. 45(Suppl. 7). — P. 306.
- Eisenberg E., Alon N., Ishay A. et al. Lamotrigine in the treatment of painful diabetic neuropathy // Eur. J. Neurol. 1998. — Vol. 5. — P. 167−173.
- Eisenberg E., Lurie Y., Braker C., et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study // Neurology. 2001. — Vol. 57. — P. 505−509.
- Eisenberg E., McNicol E.D., Carr D.B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials // JAMA. 2005. — Vol. 293. — P. 3043−3052.
- Ellrich J., Hopf H.C., Treede R.D. Nociceptive masseter inhibitory reflexes evoked by laser radiant heat and electrical stimuli // Brain Res. 1997. — Vol. 764. — P. 214−220.
- England J.D., Happel L.T., Kline D.G., et al. Sodium channel accumulation in humans with painful neuromas // Neurology. 1996. — Vol. 47. — P. 272−276.
- Ertas M., Sagduyu A., Arac N., et al. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy // Pain. 1998. — Vol. 75. — P. 257−259.
- Finnerup N.B., Jensen T.S. Mechanisms of disease: mechanismbased classification of neuropathic pain-a critical analysis // Nat. Clin. Pract. Neurol. 2006. — Vol. 2. — P. 107 115.
- Finnerup N.B., Otto M., McQuay H.J., et al. Algorithm for neuropathic pain treatment: an evidence based proposal // Pain. 2005. — Vol. 118, N. 3. — P. 289−305.
- Fishbain D. Evidence-based data on pain relief with antidepressants // Ann. Med. 2000. -Vol. 32, N. 5.-P. 305−316.
- Forkmann T., Heins M., Bruns T. et al. The second exteroceptive suppression is affected by psychophysiological factors // J. Psychosom. Res. — 2009. — Vol. 66, N. 6. — P. 521−529.
- Frampton J.E., Scott L.J. Pregabalin: in the treatment of painful diabetic peripheral neuropathy // Drugs. 2004. — Vol. 64. — P. 2813−2821.
- France C.R., Suchowiecki S. A comparison of diffuse noxious inhibitory controls in men and women // Pain. 1999. — Vol. 81. — P. 77−84.
- Fromm G.H., Terrence C.F. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia // Neurology. 1987. — Vol. 37. — P. 1725−1728.
- Fromm G.H., Terrence C.F., Chattha A.S. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up // Annals of Neurology. 1984. -Vol. 15.-P. 240−244.
- Fukushima T. Microvascular decompression for hemifacial spasm and trigeminal neuralgia: results in 4000 cases // J. Neurol. Neurosurg. Psychiat. 1990. — Vol. 53. — P. 173.
- Galer B.S., Gianas A., Jensen M.P. Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life // Diabetes Res. Clin. Pract. 2000. — Vol. 47. — P. 123−128.
- Garcia-Larrea L, Sindou M, Mauguire F. Clinical use of nociceptive flexion reflex recording in the evaluation of functional neurosurgical procedures // Acta Neurochir. Suppl. 1989.-Vol. 46.-P. 53−57.
- Gendelman N., Snell-Bergeon J.K., McFann K. et al. Prevalence and correlates of depression in individuals with and without type 1 diabetes // Diabetes Care. 2009. — Vol. 32, N.4. — P. 575−579.
- Giannini C., Dyck P.J. Pathologic alterations of human diabetic polyneuropathy // Diabetic neuropathy / Eds. Dyck P.J., Tomas P.K. 2-nd Ed. Phyladelphia: Saunders W.B., 1999.-P. 270−295.
- Gilron I., Watson C.P., Cahill C.M., Moulin D.E. Neuropathic pain: a practical guide for the clinician // CMAJ. 2006. — Vol. 175. — P. 265−275.
- Gimbel J.S., Richrds P., Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy. Arandomized controlled trial // Neurology. — 2003. — Vol. 60. — P. 927—934.
- Goadsby P.J., Lipton R.B., Ferrari M.D. Migraine current understanding and treatment // N. Engl. J. Med. — 2002. — Vol. 346. — P. 257−270.
- Gobel H., Ernst M., Jeschke J. et al. Acetylsalicylic acid activates antinociceptive brainstem reflex activity in headache patients and in healthy subjects // Pain. — 1992. — Vol. 48. — P. 187−195.
- Gobel H., Krapat S., Dworschak M. et al. Exteroceptive suppression of temporalis muscle activity during migraine attack and migraine interval before and after treatment with sumatriptan // Cephalalgia. 1994. — Vol. 14, N. 2. — P. 143−148.
- Gobel H., Schoenen J. Exteroceptive suppression in headache research. Discussion summary // Cephalalgia. 1993. — Vol. 13. — P. 20.
- Godaux E., Desmedt J.E. Exteroceptive suppression and motor control of the masseter and temporalis muscles in normal man // Brain Res. — 1975. Vol. 85. — P. 447—458.
- Goldstein D.J., Lu Y., Detke M.J., et al. Duloxetine versus placebo in patients with painful diabetic neuropathy // Pain. 2005. — Vol. 116. — P. 109−118.
- Goodnick P.J., Henry J.H., Buki V.M. Treatment of depression in patients with diabetes mellitus // J. Clin. Psychiatry. 1995. — Vol. 56, N. 4. — P. 128−136.
- Guay D.R. Pregabalin in neuropathic pain: a more 'pharmaceutically elegant' gabapentin? // Am. J. Geriatr. Pharmacother. 2005. — Vol. 3. — P. 274−287.
- Guieu R., Bun O., Pouget J., Serratnce G. Analgesic effect of indomethacin shown using the nociceptive flexion reflex in humans // Ann. Rheum. Dis. 1992. — Vol. 51. — P. 391 -393.
- Guinmand F., Dupont X., Brasseur L. et al. The effects of ketamine on the temporal summation (wind-up) of the RIII nociceptive reflex and pain in humans // Anesth. Analg. -2000. Vol. 90. — P. 408−414.
- Hakanson S. Trigeminal neuralgia treated by the injection of glycerol into the trigeminal cistern //Neurosurgery. 1981. — Vol. 9. — P. 638−646.
- Hall G.C., Carroll D., McQuay H.J. Primary care incidence and treatment of four neuropathic pain conditions: A descriptive study, 2002−2005 // BMC Family Practice. 2008. -Vol. 9.-P. 26.
- Hall G.C., Carroll D., Parry D., McQuay H.J. Epidemiology and treatment of neuropathic pain: The UK primary care perspective // Pain. — 2006. Vol. 122. — P. 156−162.
- Hamlyn P.J., King T.T. Neurovascular compression in trigeminal neuralgia: a clinical and anatomical study // J. Neurosurg. 1992. — Vol. 76. — P. 948−954.
- Harati Y., Gooch C., Swenson M., et al. Double-blind randomized trial of tramadol for the treatment of diabetic neuropathy // Neurology. 1998. — Vol. 50. — P. 1842−1846.
- Harden N., Cohen M. Unmet needs in the management of neuropathic pain // J. Pain Symptom Manage. 2003. — Bd. 25. — S. 12−17.
- Haupt E., Ledermann H., Kopcke W. Benfotiaminc in the treatment of diabetic polyneuropathy a three-week randomized, controlled pilot study (BEDIP study) // Int. J. Clin. Pharmacol. Ther. — 2005. — Vol. 43. — P. 71−77.
- Haythornthwaite J.A., Benrud-Larson L.M. Psychological aspects of neuropathic pain // Clin. J. Pain. 2000. — Bd. 16 (2 suppl.). — S.101−105.
- Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2-nd edition // Cephalalgia. 2004. — Vol. 24 (Suppl. 1). — P. 1−160.
- Hempenstall K., Nurmikko T.J., Johnson R.W., et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review // PLoS Medicine. 2005. — Vol. 2. — P. 628−644.
- Hoke A., Feasby T. Disorders of the peripheral nervous system // Kelley’s Textbook of Internal Medicine / Ed. H. Humes. Philadelphia: Lippincott Williams and Wilkins, 2000. -P. 2980−2981.
- Holroyd K.A., Stensland M., Lipchik G.L. Psychosocial correlates and impact of chronic tension-type headaches // Headache. 2000. — Vol. 40. — P. 3−16.
- Holstege G. Subcortical limbic system projections to caudal brainstem and spinal cord. //
- The Human Nervous System / Ed. Paxinos G. San Diego: Acad. Press, 1990. — P. 261−286.
- Hovinga C.A. Levetiracetam: a novel antiepileptic drug // Pharmacotherapy. 2001. -Vol. 21.-P. 1375−1388.
- Huizinga M., Peltier A. Painful diabetic neuropathy: A management-centred reviews // Clinical Diabetes. -2007. Vol. 25. — P. 6−15.
- Hussein S.M., McCall W.D. Jr. Masseteric silent periods electrically evoked in normal subjects and patients with temporomandibular joint dysfunction // Exp. Neurol. 1983. -Vol. 81.-P. 64−76.
- Jann M.W., Slade J.H. Antidepressant agents for the treatment of chronic pain and depression // Pharmacotherapy. 2007. — Vol. 27, N. 11. P. 1571−1587.
- Jannctta P.J. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia // J. Neurosurg. 1967. — Vol. 26 (Suppl). — P. 159−162.
- Jannetta P.J. Microsurgical management of trigeminal neuralgia // Arch. Neurol. 1985.-Vol. 42.-P. 800.
- Janetta P. Trigeminal neuralgia: treatment bymicrovascular decompression // Neurosurgery / Eds. Wilkins R., Regachary S. New York: McGrawy-Hill, 1996. — P. 3961−3968.
- Jensen T.S. Anticonvulsants in neuropathic pain: rationale and clinical evidence // European Journal of Pain. 2002. — Vol. 6 (Suppl. A). — P. 61−68.
- Jensen T.S., Backonja M.M., Hernandez S. et al. New perspectives on the management of diabetic peripheral neuropathic pain // Diab. Vase. Dis. Res. — 2006. Vol. 3. — P. 108−119.
- Jensen T.S., Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain // Pain. 2003. — Vol. 102. — P. 1−8.
- Jensen M.P., Chodroff M.J., Dworkin R.H. The impact of neuropathic pain on health-related quality of life: review and implications // Neurology. 2007. — Vol. 68. — P. 11 781 182.
- Jorns T. P., Johnston A., Zakrzewska J. M. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra®) in treatment of patients with trigeminal neuralgia // European Journal of Neurology. 2009. — Vol. 16. — P. 740−744.
- Jorns T.P., Zakrzewska J.M. Evidence-based approach to the medical management of trigeminal neuralgia // Br. J. Neurosurg. 2007. — Vol. 21. — P. 253−61.
- Jose V. M., Bhansali A., Hota D., Pandhi P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy // Diabet. Med. 2007. — Vol. 24. — P. 377−383.
- Kadiroglu A.K., Sit D., Kayabasi H. et al. The effect of venlafaxine HC1 on painfulperipheral diabetic neuropathy in patients with type 2 diabetes mellitus // J. Diabetes Complications. 2008. — Vol. 22, N. 4. — P. 241−245.
- Kasper D.L., Fauci A.S., Longo D.L. eds. Harrison’s Principles of Internal Medicine, 16th edn, international edition. New York: McGraw-Hill Companies, 2005. P. 2152−2179.
- Katsarava Z., Giffin N., Diener H. C, Kaube H. Abnormal habituation of 'nociceptive' blink reflex in migraine—evidence for increased excitability of trigeminal nociception // Cephalalgia. 2003.-Vol. 23.-P. 814−819.
- Kawano M. Omori Y., Katayama S. et al. A questionnaire for neurological symptoms in patients with diabetes — cross-sectional multicenter study in Saitama Prefecture, Japan // Diabetes Res. Clin. Pract. 2001. — Vol. 54. — P. 41−47.
- Keidel M., Rieschke P., Stude P. et al. Antinociceptive reflex alteration in acute posttraumatic headache following whiplash injury // Pain. — 2001. — Vol. 92, N. 3. P. 319 326.
- Khaliq W., Alam S., Puri N. Topical lidocaine for the treatment of postherpetic neuralgia // Cochrane Database Syst. Rev. 2007. — Vol. 2: CD004846.
- Kihara M., Low P.A. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy//Experimental Neurology.- 1995.-Vol. 132.-P. 180−185.
- Kimura S., Tanabe M., Honda M., Ono H. Enhanced Wind-Up of the C-Fiber-Mediated Nociceptive Flexor Reflex Movement Following Painful Diabetic Neuropathy in Mice // J. Pharmacol. Sci. 2005. — Vol. 97. — P. 195 — 202.
- Klun B. Microvascular decompression and partial sensory rhizotomy in the treatment of trigeminal neuralgia: personal experience with 220 patients // Neurosurgery. — 1992. — Vol. 30. -P. 49−52.
- Kress B., Schindler M., Rasche D. MRI volumetry for the preoperative diagnosis of trigeminal neuralgia // Eur. Radiol. 2005. — Vol. 15. P. 1344−1348.
- Kugelberg E., Eklund K., Grimby L. An electromyographic study of the nociceptive reflexes of the lower limb mechanism of the plantar responses // Brain/ 1960 -Vol. 83.-P. 394−410.
- Lai J., Hunter J.C., Porreca F. The role of voltage-gated sodium channels in neuropathic pain // Curr. Opin. Neurobiol. 2003. — Vol. 13, N. 3. — P. 291−297.
- Langemark M., Bach F.W., Jensen T.S., Olesen J. Decreased nociceptive flexion reflex threshold in chronic tension-type headache //Arch. Neurol. 1993. — Vol. 50, N. 10.-P. 1061−1064.
- Lesser H., Sharma U., LaMoreaux L., et al. Pregabalin relieves symptoms of painful diabetic neuropathy // Neurology. 2004. — Vol. 63. — P. 2104−2110.
- Lipchik G.L., Holroyd K.A., Talbot F., Greer M. Pericranial muscle tenderness and exteroceptive suppression of temporalis muscle activity: a blind study of chronic tension-type headache // Headache. 1997. — Vol. 37. — P. 368−376.
- Loeser J.D., Ward A.A. Some effects of deafferentation on neurons of the cat spinal cord // Arch. Neurol. 1967. — Vol. 17. — P. 629−636.
- Loscher W., Honack D., Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ueb L059) in the kindling model of temporal lobe epilepsy // J. Pharmacol. Exp. Ther. 1998. — Vol. 284. — P. 474−479.
- Love S., Coakham H.B. Trigeminal neuralgia: pathology and pathogenesis // Brain. -2001.-Vol. 124, N. 12.-P. 2347−2360.
- Lovely T.J., Jannetta P.J. Microvascular decompression for trigeminal neuralgia. Surgical technique and long-term results // Neurosurg. Clin. N. Am. 1997. — Vol. 8. — P. 11−29.
- Low P.A., Nickander K.K., Tntschler H.J. The roles ofoxidative stress and antioxidant treatment in experimental diabetic neuropathy // Diabetes. 1997. — Vol. 46 (Suppl. 2). -P. 38−42.
- Lukyanetz E.A., Shkryl V.M., Kostyuk P.G. Selective blockade of N-type calcium channels by levetiracetam // Epilepsia. — 2002. — Vol. 43. — P. 9—18.
- Lustman P.J., Freedland K.E., Griffith L.S. et al. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial // Diabetes Care. 2000. — Vol. 23. — P. 618−623.
- Lynch M.E. Antidepressants as analgesics: A review of randomized controlled trials // J. Psychiatry Neurosci. 2001. — Vol. 26. — P.30−36.
- MacDonald B.K., Cockerell O.C., Sander J.W., Shorvon S.D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK // Brain. 2000. — Vol. 123. — P. 665−676.
- Maertens de Noordhout A., Wang W., Schoenen J. Clinical neurophysiology and neurotransmitters // Cephalalgia. 1995. — Vol. 15. — P. 301−309.
- Maixner W., Fillingim R., Booker D., Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain // Pain. — 1995. Vol. 63. — P.341.351.
- Martin C.L., Albcrs J., Herman W.H., et al., DCCT/EDIC Research Group. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion // Diabetes Care. 2006. — Vol. 29, N. 2. P. 340−344.
- Mason L., Moore R.A., Derry S. et al. Systematic review of topical capsaicin for the treatment of chronic pain // BMJ. 2004. — Vol. 328. — P. 991−994.
- Mason P., Strassman A., Maciewicz R. Intracellular responses of raphe magnus neurons during the jaw-opening reflex evoked by tooth pulp stimulation // Brain Res. 1986. — Vol. 379.-P. 232−241.
- Mason P., Strassman A., Maciewicz R. Is the jaw-opening reflex a valid model of pain? // Brain Res. 1985. — Vol. 357. — P. 137−146.
- Max M.B., Kishore-Kumar R., Schafer S.C., et al. Efficacy of dcsipramine in painful diabetic neuropathy: A placebo-controlled trial // Pain. 1991. — Vol. 45. — P. 3−9.
- Max M.B., Lynch S.A., Muir J. et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy // N. Engl. J. Med. 1992. — Vol. 326. — P. 1250−1256.
- Mayfield J.A., Reiber G.E., Sanders L.J. et al. Preventive foot care in people with diabetes // Diabetes Care. 2003. — Bd. 26 (suppl. 1). — S. 78−79.
- McLachlan E.M., Janig W., Devor M., Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia // Nature. — 1993. — Vol. 363. P. 543 546.
- McLaughlin M.R., Jannetta P.J., Clyde B.L. et al. Microvascular decompression of cranial nerves: lessons learned after 4400 operations // J Neurosurg. 1999. — Vol. 90. — P. 1−8.
- Melzack R. Phantom limb and the concept of neuromatrix // Trends in Neurosci. 1990. Vol. 13. — P. 88−92.
- Melzack R. The McGill Pain Questionnaire: major properties and scoring methods // Pain. 1975. — Vol. 1, N. 3. — P. 277−299.
- Melzack R., Wall P.D. Pain mechanisms: a new theory // Science. 1965. — Vol. 150. — P. 971−979.
- Meyer R.A., Campbell J.N., Raja S.N. Peripheral neural mechanisms of nociception // Textbook of pain / Eds. P.D. Wall, R. Melzack. Churchill Livingstone, Edinburgh, 1994. — P. 13−44.
- Meyer-Rosberg K., Kvarnstrom A., Kinnman E. et al. Peripheral neuropathic pain a multidimensional burden for patients // Eur. J. Pain. — 2001. — Vol. 5. — P. 379−389.
- Moulin D.E., Clark A.J., Gilron I. et al. Pharmacological management of chronic neuropathic pain consensus statement and guidelines from the Canadian Pain Society // Pain Res. Manag.-2007.-Vol. 12.-P. 13−21.
- Mullan S., Lichtor T. Percutaneous microcompression of the trigeminal ganglion for trigeminal neuralgia // J. Neurosurg. 1983. — Vol. 59. — P. 1007−1012.
- Nakashima K., Takahashi K. Exteroceptive suppression of the masseter, temporalis and trapezius muscles produced by mental nerve stimulation in patients with chronic headaches // Cephalalgia.- 1991.-Vol. 11.-P. 23−28.
- Nash T.P. Treatment options in painful diabetic neuropathy // Acta Neurol. Scand. Suppl. 1999. — Vol. 173. — P. 3642.
- National Center for Health Statistics. Health. USA, 2005 with Clartbook on Trends in the Health of Americans. Hyattsville- Maryland, 2005.
- Nelson K.A., Park K.M., Robinovitz E., et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia // Neurology. — 1997. — Vol. 48.-P. 1212−1218.
- Nozaki S, Enomoto S, Nakamura Y. Identification and inputoutput properties of bulbar reticular neurons involved in the cerebral cortical control of trigeminal motoneurons in cats // Exp. Brain Res. 1983. — Vol. 49. — P. 363−372.
- Nurmikko T. Trigeminal neuralgia // Int. J. Pain. Med. Pall. Care. 2003. — Vol. 3. — P. 2−11.
- Obermann M., Yoon M.S., Sensen K. et al. Efficacy of pregabalin in the treatment of trigeminal neuralgia//Cephalalgia.-2008.-Vol. 28.-P. 174−181.
- Ochoa J.L., Yarnitsky D. Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes // Ann. Neurol. 1993. — Vol. 33. — P. 465−472.
- O’Connor A.B. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy // Pharmacoeconomics. 2009. — Vol. 27, N. 2. — P. 95−112.
- O’Connor A.B., Noyes K., Holloway R.G. A cost-utility comparison of four first-line medications in painful diabetic neuropathy // Pharmacoeconomics. 2008. — Vol. 26, N. 12.-P. 1045−1064.
- Ongerboer de Visser B.W., Cruccu G., Manfredi M., Koelman J.H.T.M. Effects of brainstem lesions on the masseter inhibitory reflex. Functional mechanisms of reflex pathways//Brain. 1990.-Vol. 113.-P. 781−792.
- Otto M., Bak S., Bach F.W., et al. Pain phenomena and possible mechanisms in patients with ainftil polyneuropathy//Pain. 2003.-Vol. 101.-P. 187−192.
- Ozyalcin S.N. Talu G.K., Kiziltan et al. The efficacy and safety of venlafaxine in the prophylaxis of migraine // Headche. 2005. — Vol. 45, N.2. — P. 144−152.
- Paoli F., Darcourt G., Corsa P. Note preliminaire su Faction de I’imipramine dans les etats douloureux // Rev. Neurol. 1960. — Vol. 2. — P. 503−504.
- Patsalos P.N. Pharmacokinetic profile of levetiraeetam: toward ideal characteristics // Pharmacol. Ther. 2000. — Vol. 85. — P. 77−85.
- Paulus W., Raubuchl O., Straube A., Schoenen J. Exteroceptive suppression of temporalis muscle activity in various types of headache // Headache. — 1992. — Vol. 32. — P. 4114.
- Pelissolo A. Depression and pain: prevalence and clinical implication // Presse Med. -2009. Vol. 38, N.3. — P. 385−391.
- Perez C., Navarro A., Saldana M.T. et al. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings // Cephalalgia. 2009. — Vol. 29. — P. 781−790.
- Pietrobon D., Striessnig J. Neurobiology of migraine // Nat. Rev. Neurosci. 2003. -Vol. 4. — P. 386−398.
- Quattrini C., Tesfaye S. Understanding the impact of painful diabetic neuropathy // Diabetes Metab. Res. Rev. 2003. — Bd. 19 (suppl. 1). — S. 2−8.
- Quilici S., Chancellor J., Lothgren M. et al. Meta-analysis of duloxctine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain // BMC Neurology.2009.-Vol. 9.-P. 6.
- Raison C.L. Pathophysiologic mechanisms of depression: implications for medical illness. Program and abstracts of the American College of Clinical Pharmacy 2005 Annual Meeting- October 22−26, 2005- San Francisco, California. P. 52.
- Rasche D., Kress B., Stippich C. ct al. Volumetric measurement of the pontomesencephalic cistern in patients with trigeminal neuralgia and healthy controls // Neurosurgery. 2006. — Vol. 59. — P. 614−620.
- Raskin P., Donofrio P.D., Rosenthal N.R., et al- CAPSS-141 Study Group. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects // Neurology. 2004. -Vol. 63.-P. 865−873.
- Raskin J., Pritchett Y.L., Wang F., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain // Pain Med. 2005. — Vol. 6. — P. 346−356.
- Raudino F. Is temporomandibular dysfunction a cranial dystonia? An electrophysiological study // Headache. 1994. — Vol. 34. — P. 471175.
- Ray W.A., Meredith S., Thapa P.B., et al. Cyclic antidepressants and the risk of sudden cardiac death // Clin. Pharm. and Therap. 2004. — Vol. 75. — P. 234−241.
- Reichstein L., Labrenz S., Ziegler D., Martin S. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation // Diabetologia. — 2005. -Vol. 48. P. 824−828.
- Richter R.W., Portenoy R., Sharma U. et al. Relief of diabetic peripheral neuropathy with pregabalin: a randomised placebo-controlled trial // J. Pain. 2005. — Vol. 6. -P. 253−260.
- Roberts W.J. A hypothesis on the physiological basis for causalgia and related pains // Pain. 1986. — Vol. 24. — P. 297−311.
- Rosenstock J., Tuchmann M., LaMoreaux L. et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial // Pain. 2004. -Vol. 110.-P. 628−638.
- Rowbotham M.C., Goli V., Kunz N.R., et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a ouble-blind, placebo-controlled study // Pain. -2004. Vol. 110. — P. 697−706.
- Rowbotham M.C., Twilling L., Davies P. S., et al. Oral opioid therapy for chronic peripheral and central neuropathic pain // New England Journal of Medicine. 2003. — Vol. 348. — P. 1223−1232.
- Rozen T.D. Trigeminal neuralgia and glossopharyngeal neuralgia // Neurol. Clin. 2004. -Vol. 22.-P. 185−206.
- Saarto T., Wiffen P.J. Antidepressants for neuropathic pain // Cochrane Database Syst. Rev. 2007. Vol. 4: CD005454.
- Sandrini G., Andrea A., Bono G., Nappi G. The nociceptive flexion reflex as a tool for exploring pain control systems in headachc and other pain syndromes // Cephalalgia. — 1993. -Vol. 13.-P. 21−27.
- Sandrini G., Antonaci F., Lanfranchi S. at al. Asymmetrical reduction of the nociceptive flexion reflex threshold in cluster headache // Cephalalgia. 2000. — Vol. 20, N. 7. — P. 647 652.
- Sang C.N., Booher S., Gilron I., et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia. Efficacy and dose-response trials // Anesthesiology. 2002. — Vol. 96. — P. 1053−1061.
- Schmader K. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy // Clin. J. Pain. 2002. — Vol. 18. — P. 350−354.
- Schnitzler A., Ploner M. Neurophysiology and functional neuroanatomy of pain perception // J. Clin. Neurophysol. 2000. — Vol. 17, N. 6. — P. 592−603.
- Schoenen J. Clinical neurophysiology of headache // Neurol. Clin. 1997. — Vol. 15. — P. 85−105.
- Schoenen J. Exteroceptive suppression of temporalis muscle activity in patients with chronic headache and in normal volunteers: methodology, clinical and pathophysiological relevance // Headache. 1993. — Vol. 33. — P. 3−17.
- Schoenen J., Bendtsen L. Neurophysiology of tension type headache // The headaches, 2nd edn. / Eds. Olesen J., Tfelt-Hansen P., Welch K.M. Baltimore: Lippincott Williams & Wilkins, 2000. — P. 579−587.
- Schoenen J., Jamart B., Gerard P. et ill. Exteroceptive suppression of temporalis muscle activity in chronic headache // Neurology. 1987. — Vol. 37. — P. 1834−1836.
- Schoenen J., Raubuchl O., Sianard J. Pharmacologic modulation of temporalis exteroceptive silent periods in healthy volunteers // Cephalalgia. 1991. — Vol. 11 (Suppl. 11).-P. 16−17.
- Schoenen J., Sianard-Gainko J., Raubuschl O. Serotonin and temporalis exteroceptive silent periods // 5-Hydroxytryptamine mechanisms in primary headache /Eds. Olesen J., Saxena P.R. New York: Raven Press, 1992. — P. 91±97.
- Schoenen J., Wang W., Gerard P. Modulation of temporalis muscle exteroceptivesuppression by limb stimuli in normal man // Brain Res. 1994. — Vol. 657. — P. 214−220.
- Seltzer Z., Devor M. Ephaptic transmission in chronically damaged peripheral nerves // Neurology. 1979. — Vol. 29. — P. 1061.
- Sessle B.J., Hu J.W. Raphe-induced suppression of the jaw-opening reflex and single neurons in trigeminal subnucleus oralis, and influence of naloxone and subnucleus caudalis // Pain.-1981.-Vol. 10.-P. 19−36.
- Shelden C.H., Pudenz R.H., Doyle J. Electrical control of facial pain // Am. J. Surg. -1967.-Vol. 114.-P. 209−212.
- Sherrington C.S. Reflexes elicitable in the cat from pinna, vibrissae and jaws // J. Physiol. 1917. — Vol. 51. — P. 404−431.
- Shrivastava R.K. Cohn C., Crowder I., et al. Long-term safety and clinical acceptability of venlafaxine and imipramme in outpatients with major depression // Clin. Psychopharmacol. -1994. Vol. 14. — P. 322−329.
- Silberstein S.D. Migraine pathophysiology and its clinical implications // Cephalalgia. -2004. Vol. 24 (Suppl. 2). — P. 2−7.
- Sima A. Metabolic alterations of peripheral nerve in diabetes // Semin. Neurol. 1996. -Vol. 16.- P. 129−137.
- Sima A.A.F., Calvani M., Mehra M. et al. Acetyl L Carnitine improves pain, nerve regeneration and vibratory perception in patients with chronic diabetic neuropathy // Diabetes Care. 2005.-Vol. 28.-P. 96−101.
- Simpson D.A. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy // Journal of Clinical Neuromuscular Disease. — 2001. — Vol. 3. P. 53−62.
- Sindrup S.H., Andersen G., Madsen C., et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial // Pain. 1999 — Vol. 83 — P. 85−90.
- Sindrup S.H., Bach F.W., Madsen C., et al. Venlafaxine versus imipramine in painful polyneuropathy. A randomized, controlled trial // Neurology. 2003. — Vol. 60. — P. 12 841 289.
- Sindrup S.H., Gram L.F., Brosen K. et al.: The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms // Pain. — 1990.1. Vol. 42.-P. 135−144.
- Sindrup S.H., Jensen T.S. Pharmacotherapy of trigeminal neuralgia // Clin. J. Pain. -2002.-Vol. 18.-P. 22−27.
- Sindrup S.H., Otto M., Finnerup N.B., et al. Antidepressants in the treatment of neuropathic pain // Basic and Clin. Pharm. and Ther. 2005. — Vol. 96. -P. 399−409.
- Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes // JAMA. 2005. — Vol. 293. P. 217−228.
- Sinha R., Sharma R., Mathur R., Nayar U. Hypothalamolimbic involvement in modulation of tooth-pulp stimulation evoked nociceptive response in rats. // Indian J. Physiol. Pharmacol. 1999. — Vol. 43. — P. 323−331.
- Skljarevski V., Ramadan N.M. The nociceptive flexion reflex in humans // Pain. 2002.-Vol. 96.-P. 3−8.
- Slaiger T.O., Gaster B., Sullivan M.D., Deyo R.A. Systematic review of antidepressants in the treatment of chronic low back pain // Spine. 2003. — Vol. 28, N. 22. — P. 2540−2545.
- Songer D.A., Schulte H. Venlalaxine for treatment of chronic pain letter. // Am. J. Psychiatry. 1996. — Vol. 153. — P. 737.
- Stillman M. Clinical approach to patients with neuropathic pain // Cleveland Clin. J. Med. -2006. Vol. 73, N. 8. — P. 726−739.
- Sullivan S.D., Lew D.P., Devine E.B. et al. Health state preference assessment in DPN // Pharmacoeconomics. 2002. — Vol.20. — P. 1079−1089.
- Sweet W.H., Wepsic J.G. Controlled thermocoagulation of trigeminal ganglion and root for differential destruction of pain fibers. Part I: trigeminal neuralgia // J. Neurosurg. — 1974. -Vol. 39.-P. 143−156.
- Tassone D.M., Boyce E., Guyer J., Nuzum D. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders // Clin. Ther. 2007. — Vol. 29. — P. 26−48.
- Tataroglu C., Kanik A., Sahin G. et al. Exteroceptive suppression patterns of masseter and temporalis muscles in central and peripheral headache disorders // Cephalalgia. 2002. -Vol. 22. — P. 444−452.
- Tavakoli M., Malik R.A. Management of painful diabetic neuropathy // Expert. Opin. Pharmacother. 2008. — Vol. 9, N. 17. — P. 2969−2978.
- Tolle T., Dukes E., Sadosky A. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries // Pain Pract. 2006. — Vol. 6. — P. 153−160.
- Tolle T., Freynhagen R., Versavel M. et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study // Eur. J. Pain. 2008. -Vol. 12.-P. 203−213.
- Torrance N., Smith B.H., Bennett M.I., Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey // J. Pain. -2006.-Vol. 7. -P. 281−289.
- Tronnier V.M., Rasche D., Hamer J. et al. Treatment of idiopathic trigeminal neuralgia: Comparison of long-term outcome after radiofrequency rhizotomy and microvascular decompression //Neurosurgery. 2001. — Vol. 48. — P. 1261—1267.
- UK Prospective Diabetes study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPD S3 8 // BMJ. -1998.-Vol. 317.-P. 703−713.
- Vallis-Sole J., Vila N., Obach V. et al. Brain stem reflexes in patients with Wallenberg’s syndrome: correlation with clinical and magnetic resonance imaging (MRI) findings // Muscle Nerve. 1996. — Vol. 19. — P. 1093−1099.
- Valzania F., Strafella A., Nassetti S. et al. Gabapcntin in idiopatic trigeminal neuralgia // Neurology. 1998. — Vol. 50 (Suppl.4). — P. 379.
- Van Kleef M., Van Genderen W. E., Narouze S. et al. 1. Trigeminal Neuralgia // Pain Practice. 2009. — Vol. 9, N. 4. — 252−259.
- Varkonyi T., Kempler P. Diabetic neuropathy: new strategies for treatment // Diabetes, Obesity and Metabolism. 2008. — Vol. 10. — P. 99−108.
- Vileikyte L., Leventhal H., Gonzalez J.S. et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited // Diabetes Care. 2005. — Vol. 28. — P. 2378−2383.
- Vileikyte L., Rubin R.R., Leventhal H. Psychological aspects of diabetic neuropathic footcomplications: An overview // Diabetes Metab. Res. Rev. 2004. — Bd. 20 (suppl. 1). -S.13−18.
- Vinik A.I. Diabetic neuropathy: pathogenesis and therapy // Am. J. Med. 1999. — Vol. 107 (Suppl. 2).-P. 17−26.
- Vinik A.I., Mehrabyan A. Diabetic neuropathies // Med. Clin. North. Am. 2004. — Vol. 88. — P. 947−999.
- Vinik A., Ullal J., Parson H., Casellini C.M. Diabetic neuropathies: clinical manifestations and current treatment options // Nat. Clin. Pract. Endocrinol. Metab. — 2006. -Vol. 2, N. 5. — P. 269−281.
- Wada R., Yagihashi S. Role of advanced glycation end products and their reccptors in development of diabetic neuropathy // Ann. N. Y. Acad. Sci. 2005. Vol. 1043. — P. 598 604.
- Wall P.D. Mechanisms of acute and chronic pain // Advances in pain research and therapy / Eds.: L. Kruger, J.C. Liebeskind. New York, Raven Press. — 1984. — Vol. 6. — P. 95−104.
- Wallasch T.M., Gobel H. Exteroceptive suppression of temporalis muscle activity: findings in headache // Cephalalgia. 1993. — Vol. 13. — P. 11−14.
- Wallasch T.M., Lindner V., Soyka D. Temporalis-inhibitory reflex in the assessment of the functional state of the pain control system in chronic headache sufferers // Headache. — 1992 Vol. 3,-P. 43133.
- Wallasch T.M., Reinecke M., Langohr H.D. EMG analysis of the late exteroceptive suppression period of temporal muscle activity in episodic and chronic tension-type headaches//Cephalalgia.-1991.-Vol. 11.-P. 109−112.
- Wang W., De Pasqua V., Gerard P., Schoenen J. Specifity and sensitivity of temporalis ES2 measurements in the diagnosis of chronic primary headaches // Headache. 1995. -Vol. 35.-P. 85−88.
- Wang W., Fu X., Wang Y. Temporalis exteroceptive suppression in generalized anxiety disorder and major depression // Psychiatry Res. — 2000. — Vol. 96. P. 149−155.
- Wang W., Schoenen J. Reduction of temporalis ES2 by peripheral electrical stimulation in migraine and tension type headaches // Pain. 1994. — Vol. 59. — P. 327−334.
- Wasan A.D., Ossanna M.J., Raskin J. et al. Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients // Curr. Drug. Saf. 2009. Vol. 4, N. 1. P. 22−29.
- Watson C.P., Moulin D., Watt-Watson J., et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy // Pain. — 2003.-Vol. 105.-P. 71−78.
- Weigel G., Kenneth F., Casey M. Striking Back! Gainesville: Trigeminal Neuralgia Association- 2000.
- Welch K.M.A. Contemporary concepts of migraine pathogenesis // Neurology. — 2003. — Bd. 61 (Suppl. 4). S.2−8.
- Wernicke J.F., Pritchett Y.L., D’Souza D.N. et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain // Neurology. — 2006. — Vol. 67.-P. 1411−1420.
- Wernicke J.F., Wang F., Pritchett Y.L. et al. An Open-Label 52-Week Clinical Extension Comparing Duloxetine with Routine Care in Patients with Diabetic Peripheral Neuropathic Pain // Pain Med. 2007. — Vol. 8, N. 6. — P. 503−513.
- Wiffen P., Collins S., McQuay H. et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst. Rev. 2005. — Vol. 3: CD001133.
- Wiffen P., McQuay H., Edwards J., et al. Gabapentin for acute and chronic pain. Cochrane Database Systematic Reviews. 2005. — Vol. 20: CD005452.
- Wiffen P.J., McQuay H.J., Moore R.A. Carbamazepine for acute and chronic pain. Cochrane Database Syst. Rev. 2005. — Vol. 3: CD005451.
- Wild S., Roglic G., Green A. et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 // Diabetes Care. 2004. — Vol. 27. — P. 1047−1053.
- Wilier J.C., Bathien N. Pharmacological modulations on the nociceptive flexion reflex in man //Pain. 1977. -Vol. 3, N. 2.-P. 111−119.
- Wilier J.C., Boureau F., Albe-Fessard D. Supraspinal influences on nociceptive flexion reflex and pain sensation in man // Brain Res. 1979. — Vol. 179. — P. 61−68.
- Woolf C.J. Pain: moving from symptom control toward mechanism-specific pharmacologic management // Ann. Intern. Med. 2004. — Vol. 140. — P. 441−451.
- Woolf C., Mannion R. Neuropathic pain: aetiology, symptoms, mechanisms, and manegenent // Lancet. 1999. — Vol. 353. -P. 1959−1964.
- Woolf C.J. Shortland P., Coggeshall R.E. Peripheral nerve injury triggers central sprouting of myelinated afferents // Nature. 1992. — Vol. 355. — P. 75−78.
- Young R.F., Vermulen S., Posewitz A. Gamma knife radiosurgery for the treatment of trigeminal neuralgia// Stereotact. Funct. Neurosurg- 1998-Vol. 70(Suppl. 1).-P. 192−199.
- Zakrzewska J.M. Consumer views on management of trigeminal neuralgia // Headache. -2001. Vol. 41. — P. 369−376.
- Zakrzewska J.M., Chaudhry Z., Nurmikko T.J., et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial // Pain.1997. Vol. 73. — P. 223−230.
- Zakrzewska J.M., Lopez B.C. Trigeminal neuralgia // Clin. Evid. 2005. — Vol. 14. — P. 1669−1677.
- Ziegler D. Glycemic control // Textbook of Diabetic Neuropathy Eds. Gries F.A., Cameron N.E., Low P.A., Ziegler D. Thieme: Stuttgart, New York, 2003. — P. 91−96.
- Ziegler D. Painful diabetic neuropathy: treatment and future aspects // Diabetes Metab. Res. Rev. 2008. — Bd. 24 (Suppl. 1). — S. 52−57.
- Ziegler D. Thioctic acid for patients with symptomatic diabetic neuropathy. A critical review // Treat. Endocrinol. 2004. Vol. 3. — P. 1−17.
- Ziegler D., Ametov A., Barinov A., et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial // Diabetes Care. 2006. — Vol. 29.-P. 2365−2370.
- Ziegler D., Nowak II., Kempler P. et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant a-lipoic acid: a meta-analysis // Diabet. Med. 2004. -Vol. 21.-P. 114−121.
- Zissis N.P., Harmoussi S., Vlaikidis N. et al. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache // Cephalalgia. 2007. — Vol. 27. — P. 315−324.
- Zwart J.A., Sand T. Exteroceptive suppression of temporalis muscle activity: a blind study of tensiontype headache, migraine, and cervicogenic headache // Headache. 1995. — Vol. 35.-P. 338−343.